IBNSINA The Ibn Sina Pharmaceutical Industry Ltd.
Pharmaceuticals & Chemicals
Tk 300.9 as of 2026-11-12 14:00:00
Rank 62 of all scored
Data completeness 100%
Data completeness 100%
Score breakdown
Consistency 79
Profitability 69
Solvency 87
Valuation 67
Weights: consistency 30%, profitability 30%, solvency 20%, valuation 20%; then risk flags add or subtract points. Full method
Why this score
Strengths
- Consistency Paid a dividend every year (5/5)
- Profitability Average ROE 21.17% (efficient: above 15%)
- Solvency Low debt: debt/equity 0.43x (below 0.5)
- Valuation P/E 11.57 is low (general benchmark ≤ 12)
Notes
- Consistency EPS rose in 2 of 4 years (mixed)
Risk flags
- Mid cap (Tk 200-1,000 cr)
- Thin trading (last day ~Tk 0.08 cr)
- Within 3.9% of its 52-week low: check WHY before treating it as cheap
Valuation
P/E
P/E audited
P/E current
P/B
NAV per share
EPS (last audited year)
Graham fair value
Margin of safety
52-week range
3.9% above the low, 18.9% below the high. Near the low is only interesting if profit is intact (see concerns above) and the fall has a temporary cause.
Quality and growth
ROE
ROE avg
ROE min
Profit CAGR
Profit YoY
Net profit
EPS up
Loss years (last ~5)
Dividends and safety
Div years
Dividend yield
Payout
Cash div
D/E
Loans/MCap
Size, liquidity and ownership
MCap
Free float
Daily turnover
Sponsor %
Inst. %
Public %
Foreign %
Shareholding
- Sponsor/director 44.7%
- Institution 25.7%
- Public 29.6%
Audited history
| Year | EPS (Tk) | NAV/share | Net profit (cr) | Cash div % | Bonus % |
|---|---|---|---|---|---|
| 2021 | 15.66 | 68.69 | 49 | 47 | 0 |
| 2022 | 19.39 | 83.36 | 61 | 60 | 0 |
| 2023 | 19.38 | 96.68 | 61 | 60 | 0 |
| 2024 | 21.46 | 111.94 | 67 | 63 | 0 |
| 2025 | 20.27 | 125.69 | 63 | 64 | 0 |
Fiscal year ends June. EPS, NAV and profit are as audited by the company and published by DSE. Financials last fetched: 14/11/2026.
Shariah screen (partial)
Business screen and the debt ratio (loans / market cap 21.8%, limit 33%) are automated. Interest income (under 5% of revenue) and cash/investment ratios must be checked in the annual report.
Educational, not investment advice. Verify on DSE and StockNow before making any decision.